GGFSX
Price
$22.76
Change
+$0.04 (+0.18%)
Updated
Jun 22 closing price
Net Assets
143.75M
RPFGX
Price
$77.34
Change
+$0.26 (+0.34%)
Updated
Jun 22 closing price
Net Assets
1.13B
Interact to see
Advertisement

GGFSX vs RPFGX

GGFSX vs RPFGX Comparison Chart in %
View a ticker or compare two or three
VS
GGFSX vs. RPFGX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGFSX is a Hold and RPFGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPFGX has more cash in the bank: 1.13B vs. GGFSX (144M). GGFSX pays higher dividends than RPFGX: GGFSX (1.63) vs RPFGX (1.37). GGFSX was incepted earlier than RPFGX: GGFSX (8 years) vs RPFGX (35 years). GGFSX (1.62) is less costly to investors than RPFGX (0.94). RPFGX is a more actively managed with annual turnover of: 10.00 vs. GGFSX (9.00). GGFSX initial investment is less costly to investors than RPFGX (5%) vs RPFGX (5%). GGFSX (1000) and RPFGX (1000) have matching initial minimum investment requirements. GGFSX annual gain was more profitable for investors over the last year : 30.00 vs. RPFGX (12.33). GGFSX return over 5 years is better than : 121.46 vs. RPFGX (51.18).
GGFSXRPFGXGGFSX / RPFGX
Total Expense Ratio1.250.94133%
Annual Report Gross Expense Ratio1.620.94172%
Fund Existence8 years35 years-
Gain YTD6.567-2.558-257%
Front Load6%5%121%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets144M1.13B13%
Annual Yield % from dividends1.631.37119%
Returns for 1 year30.0012.33243%
Returns for 3 years114.3174.29154%
Returns for 5 years121.4651.18237%
Returns for 10 yearsN/A131.06-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIBAX40.13N/A
N/A
Sit Balanced
ASRIX8.81N/A
N/A
Invesco Global Real Estate Income R5
FSGGX21.68N/A
N/A
Fidelity Global ex US Index
FBTDX156.97N/A
N/A
Franklin Biotechnology Discovery C
BMSYX17.20N/A
N/A
MFS Blended Research Mid Cap Eq R6